Volume 16, Issue 1 (January 2018)                   IJRM 2018, 16(1): 19-30 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Chinwe G S, Azuka O I, Adaeze N C. Resveratrol supplementation rescues pool of growing follicles and ovarian stroma from Cisplatin-induced toxicity on the ovary in Sprague-Dawley rats: An experimental study. IJRM 2018; 16 (1) :19-30
URL: http://ijrm.ir/article-1-945-en.html
Resveratrol supplementation rescues pool of growing follicles and ovarian stroma from Cisplatin-induced toxicity on the ovary in Sprague-Dawley rats: An experimental study
Gbotolorun Stella Chinwe * 1, Okafor Izuchukwu Azuka2 , Ndoeche Chidinma Adaeze2
1- Anatomy Department, College of Medicine of the University of Lagos, Lagos State, Nigeria. , sgbotolorun@unilag.edu.ng
2- Anatomy Department, College of Medicine of the University of Lagos, Lagos State, Nigeria
Abstract:   (3313 Views)
Background: Cisplatin is a potent antineoplastic agent for many cancers but causes several levels of gonadal damage. Ovarian toxicity is a major concern of young cancer patients undergoing chemotherapy.
Objective: This study sought to examine the effect of Cisplatin and Resveratrol supplementation on ovarian function in Sprague-Dawley rats.
Materials and Methods: In this experimental study, 45 cyclic Sprague-Dawley rats with an average weight of 160 gr were divided into 9 groups (n=5/group). Group 1 was used as control and received distilled water. Groups 2 and 9 received Cisplatin only. Groups 3, 4, and 5 received different doses of Resveratrol after a single dose of Cisplatin. Groups 6, 7, and 8 received Resveratrol before Cisplatin. At sacrifice, the ovary was analyzed for histopathology, biochemical indices of oxidation and hormonal assay.
Results: Relative and absolute organ weights were notably increased (p=0.001, 0.01) in the prophylactic groups relative to the groups that received Resveratrol after Cisplatin. Also, glutathione, superoxide dismutase and catalase were significantly increased (p=0.047, 0.01, 0.023) in a dose-dependent manner when compared to Cisplatin group only. Malondialdehyde decreased significantly (p=0.001) in the groups that received high dose Resveratrol compared with the control and Cisplatin alone groups. Although oestrogen showed no significant difference within the groups (p=0.48), Resveratrol significantly increased progesterone, follicle stimulating hormone and luteinizing hormone levels (p=0.007, 0.001, 0.006) at high doses when compared with Cisplatin alone groups. Ovarian histoarchitecture was best preserved in the prophylactic groups in a dose-dependent manner.
Conclusion: Resveratrol supplementation confers protection and preserves ovarian follicles from Cisplatin toxicity in Sprague-Dawley rats.
Keywords: Cisplatin, Ovary, Resveratrol, Sprague-Dawley rat
Full-Text [PDF 1135 kb]   (1038 Downloads) |   |   Full-Text (HTML)  (1104 Views)  
Type of Study: Original Article |
References
1. Celotti E, Ferrarini R, Zironi R, Conte LS. Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone. J Chromatogr A 1996; 730: 47-52. [DOI:10.1016/0021-9673(95)00962-0]
2. Dobrzyńska MM. Resveratrol as a promising natural radioprotector: A Review. Rocz Panstw Zakl Hig 2013; 64: 255-262.
3. Tomé-Carneiro J, Gonzálvez M, Larrosa M, Yá-ez-Gascón MJ, García-Almagro FJ, Ruiz-Ros JA, et al. Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective. Ann N Y Acad Sci 2013; 1290: 37-51. [DOI:10.1111/nyas.12150]
4. Einhorn LH. Treatment of testicular Cancer: a new and improved model. J Clin Oncol 1998; 8: 1777-1781. [DOI:10.1200/JCO.1990.8.11.1777]
5. Hong KO, Hwang JK, Park KK, Kim SH. Phosphorylation of c- Jun N-terminal Kinases (JNKs) is involved in the preventive effect of xanthorrhizol on Cisplatin-induced hepatotoxicity. Arch Toxicol 2005; 79: 231-236. [DOI:10.1007/s00204-004-0623-7]
6. Ali BH, Al Moundhri MS. Agents ameliorating or augmenting the nephrotoxicity of Cisplatin and other platinum compounds: A review of some recent research. Food Chem Toxicol 2006; 44: 1173-1183. [DOI:10.1016/j.fct.2006.01.013]
7. Shin S, Jeon JH, Park D, Jang MJ, Choi JH, Choi BH, et al. Trans-Resveratrol relaxes the corpus cavernosum ex vivo and enhances testosterone levels and sperm quality in vivo. Arch Pharmacol Res 2008; 31: 83-87. [DOI:10.1007/s12272-008-1124-7]
8. Athar M, Back JH, Kopelovich L, Bickers DR., Kim AL. Multiple molecular targets of Resveratrol: Anti-carcinogenic mechanisms. Arch Biochem Biophys 2009; 486: 95-102. [DOI:10.1016/j.abb.2009.01.018]
9. Pathak L, Agrawal Y, Dhir A. Natural polyphenols in the management of major depression. Expert Opin Investig Drugs 2013; 22: 863-880. [DOI:10.1517/13543784.2013.794783]
10. Hamadi N, Mansour A, Hassan MH, Khalifi-Touhami F, Badary O. Ameliorative effects of resveratrol on liver lnjury in streptozotocin-lnduced diabetic rats. J Biochem Mol Toxicol 2012; 26: 384-392. [DOI:10.1002/jbt.21432]
11. Shin S, Jeon JH, Park D, Jang MJ, Choi JH, Choi BH, et al. Trans-Resveratrol relaxes the corpus cavernosum ex vivo and enhances testosterone levels and sperm quality in vivo. Arch Pharm Res 2008; 31: 83-87. [DOI:10.1007/s12272-008-1124-7]
12. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: The National Academies Press; 1996.
13. Juan ME, Vinardell MP, Planas JM. The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J Nutr 2002; 132: 257-260. [DOI:10.1093/jn/132.2.257]
14. Liu M, Yin Y, Ye X, Zeng M, Zhao Q, Keefe DL, et al. Resveratrol protects against age-associated infertility in mice. Hum Reprod 2013; 28: 707-717. [DOI:10.1093/humrep/des437]
15. Azu OO, Duru FIO, Osinubi AA, Oremosu AA, Norohna CC, Okanlawon AO, et al. Long-term treatment with Kigelia Africana fruit extract ameliorates the testicular toxicity following Cisplatin administration in male Sprague-Dawley rats. J Med Plants Res 2011; 5: 388-397.
16. Dkhil MA, Al-Quraishy S, Aref AM, Othman MS, El-Deib KM, Abdel Moneim AE. The potential role of azadirahta indica treatment on cisplatin-induced hepatotoxicity and oxidative stress in female rats. Oxid Med Cell Longev 2013; 2013: 741817. [DOI:10.1155/2013/741817]
17. Sadrkhanloo R, Hofeditz C, Erickson GF. Evidence for widespread atresia in the hypophysectomized estrogen-treated rat. Endocrinol 1987; 120: 146-155. [DOI:10.1210/endo-120-1-146]
18. Rukkumani R, Aruna K, Varma PS, Rajasekaran KN, Menon VP. Comparative effects of curcumin and an analog of curcumin on alcohol and PUFA induced oxidative stress. J Pharm Pharm Sci 2004; 7: 274-283.
19. Sun Y, Oberley LW, Li Y. A Simple method for clinical assay of superoxide dismutase. Clin Chem 1998; 34: 497-500.
20. Accu Bind enzyme-linked immunoabsorbent assay (ELISA) procedure, 2016; Monobind Inc. Lake forest CA USA. Accessed 15th August, 2016.
21. Fremont L. Biological effects of resveratrol. Life Sci 2000; 66: 663-673. [DOI:10.1016/S0024-3205(99)00410-5]
22. Sexton E, Van Themsche C, LeBlanc K, Parent S, Lemoine P, Asselin E. Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells. Mol Cancer 2006; 5: 45. [DOI:10.1186/1476-4598-5-45]
23. Özcan P, Fıçıcıoğlu C, Yıldırım ÖK, Özkan F, Akkaya H, Aslan İ. Protective effect of resveratrol against oxidative damage to ovarian reserve in female sprague-dawleyrats. Reprod Biomed Online 2015; 31: 404-410. [DOI:10.1016/j.rbmo.2015.06.007]
24. Burgess TA, Robich MP, Chu LM, Bianchi C, Sellke FW. Improving glucose metabolism with resveratrol in a swine model of metabolic syndrome through alteration of signaling pathways in the liver and skeletal muscle. Arch Surg 2011; 146: 556-564. [DOI:10.1001/archsurg.2011.100]
25. Helal MAL. Chemotherapeutic agent-Induced ovarian gonadotoxicity. J Exper Biol Agric Sci 2014; 2: 583-591.
26. Sellers RS, Morton D, Michael B, Roome N, Johnson JK, Yano BL, et al. Society of toxicologic pathology position paper: organ weight recommendations for toxicology studies. Toxicol Pathol 2007; 35: 751-755. [DOI:10.1080/01926230701595300]
27. Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 2000; 169: 123-131. [DOI:10.1016/S0303-7207(00)00365-8]
28. Luo C, Urgard E, Vooder T, Metspalu A. The role of COX-2 and Nrf2/ARE in antiinflammation and antioxidative stress: aging and anti-aging. Med Hypotheses 2011; 77: 174-178. [DOI:10.1016/j.mehy.2011.04.002]
29. Schmatz R, Perreira LB, Stefanello N, Mazzanti C, Spanevello R, Gutierres J, et al. Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. Biochimie 2012; 94: 374-383. [DOI:10.1016/j.biochi.2011.08.005]
30. Yuluğ E, Türedi S, Alver A, Türedi S, Kahraman C. Effects of resveratrol on methotrexate-induced testicular damage in rats. Sci World J 2013; 2013: 489659. [DOI:10.1155/2013/489659]
31. Eleawa SM, Alkhateeb MA, Alhashem FH, Bin-Jaliah I, Sakr HF, Elrefaey HM, et al. Resveratrol reverses cadmium chloride-induced testicular damage and subfertility by downregulating p53 and Bax and upregulating gonadotropins and Bcl-2 gene expression. J Reprod Dev 2014; 60: 115-127. [DOI:10.1262/jrd.2013-097]
32. Bradamante S, Barenghi L, Villa A. Cardiovascular protective effects of Resveratrol. Cardiovasc Drug Rev 2004; 22: 169-188. [DOI:10.1111/j.1527-3466.2004.tb00139.x]
33. Darabi M, Ani M, Panjehpour M, Rabbani M, Movahedian A, Zarean E. Effect of estrogen receptorβ A1730G polymorphism on ABCA1 gene expression response to postmenopausal hormone replacement therapy. Genet Test Mol Biomarkers 2011; 15: 11-15. [DOI:10.1089/gtmb.2010.0106]
34. Files JA, Ko MG, Pruthi S. Bioidentical hormone therapy. Mayo Clin Proc 2011; 86: 673-680. [DOI:10.4065/mcp.2010.0714]
35. Otto AM, Faderl M, Schonenberger H. Dissociation of estrogenic and cytotoxic properties of an estrogen receptor-binding platinum complex in human breast cancer cell lines. Cancer Res 1991; 51: 3217-3223.
36. Lishko PV, Botchkina IL, Kirichok Y. Progesterone activates the principal Ca2+channel of human sperm. Nature 2011; 471: 387-391. [DOI:10.1038/nature09767]
37. Strünker T, Goodwin N, Brenker C, Kashikar ND, Weyand I, Seifert R, et al. The CatSper channel mediates progesterone-induced Ca2+influx in human sperm". Nature 2011; 471: 382-386. [DOI:10.1038/nature09769]
38. Bath LE, Wallace WH, Shaw MP, Fitzpatrick C, Anderson RA. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 2003; 18: 2368-2374. [DOI:10.1093/humrep/deg473]
39. Meirow D, Dor J, Kaufman B, Shrim A, Rabinovici J, Schiff E et al. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod 2007; 22: 1626-1633. [DOI:10.1093/humrep/dem027]
40. Hall JE. Guyton and hall textbook of medical physiology. 12th Ed. Elsevier, Philadelphia; 2015.
41. Strumberg D, Brügge S, Korn MW, Koeppen S, Ranft J, Scheiber G, et al. Evaluation of long-term toxicity in patients after Cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann Oncol 2002; 13: 229-236. [DOI:10.1093/annonc/mdf058]
42. Sadler TW. Langman's medical embryology. Lippincott Williams & Wilkins; 2011.
43. Pervaiz S, HolmeAL. Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal 2009; 11: 2851-2897. [DOI:10.1089/ars.2008.2412]
44. Carter GL, John AD, Kevin JP. Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer 2014; 21: R209-R225. [DOI:10.1530/ERC-13-0171]
45. Ortega I, Villanueva JA, Wong DH, Cress AB, Sokalska A, Stanley SD, et al. Resveratrol reduces steroidogenesis in rat ovarian theca-interstitial cells: the role of inhibition of Akt/PKB signaling pathway. Endocrinology 2012; 153: 4019- 4029. [DOI:10.1210/en.2012-1385]
46. Coskun A, Coban YK, Ciralik H. Critical ischemic time for the rat ovary: Experimental study evaluating early histopathologic changes. J Obstet Gynaecol Res 2009; 35: 330-334. [DOI:10.1111/j.1447-0756.2008.00874.x]
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb